Home > News > featured news > H2O.ai Showcases Healthcare and Life Sciences Leadership with Customer Successes, Breadth of AI Apps at HIMSS 2022

Health Technology

H2O.ai Showcases Healthcare and Life Sciences Leadership with Customer Successes, Breadth of AI Apps at HIMSS 2022

H2O.ai | March 14, 2022

H2O.ai, the AI Cloud leader, announced it has expanded its healthcare capabilities, now offering 40 AI applications across population health, precision medicine, public health and intelligent supply chain, supporting customers throughout the healthcare ecosystem including Bon Secours Mercy Health and Kaiser Permanente.
The company will demonstrate its technologies at the healthcare industry’s flagship technology conference, HIMSS, in Booth No. 8141, March 15-17 at the Orange County Convention Center in Orlando.

Healthcare and life sciences organizations have been stretched thin over the past few years and are actively looking for new technologies to streamline operations and improve patient outcomes across the private and public sectors. AI will empower physicians, hospital administrators, researchers and pharmaceutical companies with models and applications that produce more affordable, more accessible and more efficient healthcare. H2O.ai is at the forefront of this effort, helping organizations rapidly transform to improve health equity, access and care.

For example, the Center for Digital Health Innovation (CDHI) at the University of California, San Francisco (UCSF) is collaborating with H2O.ai on the development and training of AI algorithms that automate the processing of the 1.4 million faxed patient referrals and other documents that UCSF’s health system receives annually. The algorithms identify, classify and prioritize document types. For referrals, the AI extracts key patient data, history and relevant health information that will assist staff and eliminate manual data entry and validation tasks.

“AI in healthcare has the potential to dramatically improve the operational processes that can prevent patients from getting care quickly, at the right place, and from the right provider. Our work with H2O.ai for health document handling is just one aspect of the transformation in the ways patients access and receive care.”

Alon Konchitsky, associate director for data science and machine learning at CDHI

H2O.ai has developed 40 AI apps supporting various components of the healthcare ecosystem, including

Population Health

H2O.ai’s Covid-19 hospital occupancy simulator allows hospital administrators to track, predict and manage Covid-19-related hospital admissions by U.S. county. The company also has a pop-up predictor that allows for the quick identification of specific addresses in the U.S. that would be most suitable for temporary vaccination clinics, mobile testing centers, public education stands and more. H2O.ai’s customers - leading providers, payers and accountable care organizations (ACOs) - are developing and deploying AI models and apps around patient no shows, 30-day readmission predictors, risk stratification and omni-channel patient engagement NLP.

Precision Medicine

H2O.ai has developed a gene mutation app, a machine learning-powered patient risk assessment application that uses the Snowflake Data Cloud and the H2O AI Cloud to bring intelligent clinical decision support directly to clinicians. In another use case, H2O.ai’s gene expression tumor classification app uses gene expression information from patient biopsies to evaluate the risk of malignancy and understand how common the risk has been among past patients.

“H2O AI Cloud, integrated with the Snowflake Data Cloud, is making it easier for health organizations to rapidly develop precision medicine solutions,” said Todd Crosslin, Global Head of Healthcare and Life Sciences at Snowflake. “The Gene mutation app is just the beginning of our health partnership and our ability to deliver improved care and patient outcomes.”

Public Health

The company’s Covid-19 forecasting application enables hospital staff, policymakers and others to predict the next wave of infection as well as potential case and death rates. H2O.ai also provides a vaccine sentiment tool that leverages natural language processing (NLP) to understand the sentiment around Covid-19 vaccines, and the company is currently working with leaders to address the risks and care associated with PASC (AKA Long COVID).

Intelligent Supply Chain

To provide intelligent supply chain support, H2O.ai’s route optimizer application helps health manufacturers best optimize transportation routes to ensure products arrive on time and to standard. H2O.ai also has developed an order and inventory management app to aid health manufacturers’ inefficient warehouse and inventory management decisions.

Avoiding AI “Pilot-itis”

Many health and life sciences organizations are struggling to implement AI projects that improve patient outcomes, reduce costs and more. Through its expertise and the H2O AI Cloud platform, H2O.ai is able to break companies out of the pilot cycle and successfully take them to AI maturity to deliver impactful results. In fact, H2O.ai has experienced an increase in healthcare customers moving from the pilot phase to full-blown production AI programs.

“Artificial Intelligence and deep learning are not only driving the latest innovations in medicine but also are enabling healthcare organizations to connect fragmented data into a format that can be used to improve operational efficiency and provide more user-centric patient experiences,” said Sri Ambati, CEO and co-founder of H2O.ai. “From its use in drug discovery and forecasting the next COVID-19 variant to streamlining supply chain operations and reducing healthcare worker churn, AI will have a significant impact on democratizing health and improving patient outcomes.”

About H2O.ai
H2O.ai is the leading AI cloud company, on a mission to democratize AI for everyone. Customers use the H2O AI Cloud platform to rapidly solve complex business problems and accelerate the discovery of new ideas. H2O.ai is the trusted AI provider to more than 20,000 global organizations, including AT&T, Bon Secours Mercy Health, Capital One, Commonwealth Bank of Australia, GlaxoSmithKline, Hitachi, Kaiser Permanente, Procter & Gamble, PayPal, PwC, Reckitt, Unilever and Walgreens, over half of the Fortune 500 and one million data scientists. Goldman Sachs, NVIDIA and Wells Fargo are not only customers and partners, but strategic investors in the company. H2O.ai’s customers have honored the company with a Net Promoter Score (NPS) of 78— the highest in the industry based on breadth of technology and deep employee expertise. The world’s top 20 Kaggle Grandmasters (the community of best-in-the-world machine learning practitioners and data scientists) are employees of H2O.ai. A strong AI for Good ethos to make the world a better place and Responsible AI drive the company’s purpose. Please join our movement at H2O.ai.

Spotlight

Graft-Versus-Host Disease Prevention

Watch to see how changes in technology are helping to prevent graft-versus-host disease in cancer patients who receive bone marrow or stem cell transplants.

More featured news

Spotlight

Graft-Versus-Host Disease Prevention

Watch to see how changes in technology are helping to prevent graft-versus-host disease in cancer patients who receive bone marrow or stem cell transplants.

Related News

AI, Healthcare Analytics

Hyro Partners with Gozio Health to Integrate AI-Powered Communications with Mobile Solutions for Patients

PRNewswire | July 31, 2023

Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, customizable, location-aware mobile patient engagement platform. Hyro will embed its conversational AI platform within Gozio's framework, providing quality omnichannel voice and chat AI experiences to patients and staff through mobile applications. The partnership will initially be rolled out across the two companies' mutual customer base of healthcare providers, including Novant Health and Baptist Health. Hyro's Adaptive Communications Platform will augment Gozio's suite of mobile offerings and give enterprise health systems access to integrated AI assistants for patient-facing tasks such as prescription refills, FAQ resolution, appointment management, and troubleshooting. Together, Gozio and Hyro enable healthcare organizations to automate routine tasks so that staff can devote their full attention to more urgent responsibilities, while also removing access barriers for patients by offering them a wider range of self-service capabilities in one centralized, user-friendly location. The partnership comes amid ballooning demand for AI technologies within healthcare providers' patient interfaces to further reduce inefficiencies and streamline routine tasks in an effort to optimize staff workflows. The healthcare industry, however, is sensitive and heavily regulated, particularly concerning patient data privacy and security. As such, responsible AI implementation to help both staff and patients while still protecting personal data is of paramount importance–a mission to which Gozio and Hyro are no strangers. Hyro reaches 60-70% resolution rates for inbound calls and messages while explaining the outputs of those AI-powered interactions, ensuring a greater degree of accountability and trust surrounding technologies like Large Language Models (LLMs) and Natural Language Understanding (NLU) "With burnout and staffing shortages so widespread in healthcare, any support we can offer to already overloaded contact centers is extremely valuable," said Israel Krush, CEO and Co-Founder, Hyro. "We welcome the opportunity to partner with Gozio, expanding our omnichannel AI-powered conversations relating to scheduling, Rx management, physician search and more to their seamless mobile interfaces. Now, patients can unlock 24/7 access to critical services from their healthcare providers with zero hold times and full confidence in their automated support." "With conversational AI having burst into the public spotlight throughout 2023, we are truly excited to bake Hyro's best-in-class conversational AI solution into our mobile app," said Lee Jones, Chief Product Officer at Gozio Health. "Hyro's explainable, plug-and-play conversational AI tools will allow the healthcare providers we work with to curate the datasets that AI draws upon, save stretched operational dollars, and maintain compliance with industry regulations." Through successful collaborations with leading health systems across the US, Hyro and Gozio will continue to provide healthcare enterprises with an unparalleled, all-in-one mobile app solution, ensuring seamless support and an enhanced user experience. "In today's world, we are used to having information right at our fingertips," said Melanie Husk, SVP, Chief Consumer Officer at Baptist Health. "Through embracing the joint capabilities of these two leading innovators in digital health, we will be able to automatically incorporate the latest developments in AI and mobile technology for the benefit of our patients at Baptist Health. Patients can now request services via phone call, SMS or directly through the mobile app, no matter the time or place, to ensure easy and real-time access to care." About Hyro Hyro, the leading Conversational AI Platform for Healthcare, enables health systems to automate workflows and conversations across their most valuable platforms, services and channels—including call centers, websites, SMS, mobile apps and more. Hyro's plug-and-play approach helps organizations recapture time and investment lost to building and maintaining chat and voice solutions. Hyro's clients, which include Intermountain Healthcare, Baptist Health, and Novant Health, benefit from AI assistants that are 60x faster to deploy, easy to maintain and simple to scale—generating better conversations, more conversions, and revenue-driving insights. Headquartered in New York, Hyro was founded in 2018 by Israel Krush and Rom Cohen. About Gozio Health Gozio Health partners with health systems to increase consumer engagement using a proven mobile platform and strategy. The entire healthcare journey–both in-person and digital–is improved by giving systems the flexibility to consolidate all their patient-facing digital solutions into one premium native mobile experience accessible by anyone, anywhere. Combined with Gozio's patented indoor positioning technology, the platform empowers consumers to confidently navigate their healthcare journey and enables health systems to more effectively achieve their business goals. Gozio customers surveyed in a 2021 KLAS Research Emerging Technology Spotlight report found 100% satisfaction.

Read More

Digital Healthcare

WELL's CRH Medical Continues Digitization Progress with Strategic Investment in Graphium Health

PRNewswire | June 26, 2023

WELL Health Technologies Corp. a practitioner focused digital health company that is positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to provide key business updates to its wholly owned subsidiary CRH Medical Corp. ("CRH"). CRH Medical, a subsidiary of WELL Health Technologies, announces a significant milestone in its pursuit of enhancing digitization across the CRH platform with the recent strategic investment in Graphium Health LP ("Graphium"). This investment marks a pivotal moment in CRH's history as it continues to prioritize technology enablement to deliver performance enhancement and improved patient experiences. In the fourth quarter of 2021, CRH embarked on a journey to transition its RCM service partners, aiming to modernize and optimize its overall RCM performance. This process revealed opportunities for CRH to leverage technologically enabled point solutions, including artificial intelligence (AI), process automation, data analytics, and patient-focused data science. Through these innovations, CRH is well on its way to transforming its RCM capabilities and disseminating these advancements throughout the broader WELL Health Technologies ecosystem. To capitalize on these opportunities, CRH has recently made a strategic investment in Graphium Health LP, a leading provider of electronic medical record (EMR) solutions primarily serving anesthesia practices in both inpatient and outpatient settings across the United States. CRH Anesthesia, a part of CRH, began a successful pilot program with Graphium's products in two sites under a commercial contract signed in 2022. Based on a recent pilot project with Graphium Health, CRH has demonstrated that it was able to: 1- reduce delays and as such expedite charge capture by 58% or 5.6 days and 2- Reduce its overall AR at the sites affected by the pilot project by 24%. As a result of this investment, CRH Medical plans to expand this initiative to at least 54 additional ambulatory surgical centers (ASCs) over the next three years, where CRH provides anesthesia services. Notably, nearly one-third of CRH Anesthesia's sites currently operate without an EMR, relying solely on paper-based systems. By implementing Graphium's software in these ASCs, CRH will achieve full EMR digitization across its entire platform, ensuring seamless integration and streamlined operations. CRH has made numerous advancements to digitize its business since its acquisition by WELL more than two years ago, resulting in several tangible business improvements, including improving insurance and patient accounts receivable recovery, enhancing denial management performance, and expediting charge capture reconciliation. "We are thrilled to announce our strategic investment in Graphium Health. This transition to advanced technology solutions aligns perfectly with our commitment to improving performance and enhancing the provider and partner experience," said Jay Kreger, CEO of CRH. "By harnessing the power of artificial intelligence, process automation, and data analytics, we are empowering our team to deliver more accurate billing information, expedite charge capture reconciliation, and drive improved collections. This investment reinforces our dedication to digitization and innovation in healthcare technology." The investment in Graphium Health aligns with WELL Health Technologies' original thesis for acquiring CRH Medical, emphasizing the realization of digitization benefits across the CRH Medical platform and helping "tech enable" care providers and their support personnel. Preliminary findings from the implementation of Graphium's software have demonstrated the potential for significant RCM improvements, including quicker and more accurate billing information. After broader implementation across CRH's ASCs, Graphium's software is expected to holistically drive improved collections and enhanced data mining capabilities to deliver better analytics across the platform. WELL Health Technologies remains committed to driving digitization efforts at CRH Medical, empowering healthcare providers to deliver better and more efficient care to their patients. Through ongoing innovation and strategic investments, WELL, through CRH, further establishes itself as a leader in healthcare technology solutions. About WELL Health Technologies Corp. WELL is a practitioner-focused digital healthcare company. WELL's overarching mission is to positively impact health outcomes by leveraging technology to empower healthcare practitioners and their patients globally. WELL exists to enable healthcare practitioners with best-in-class technology and services. WELL has built the most comprehensive end-to-end healthcare system across Canada including the nation's largest network of clinics supporting primary care, specialized care, and diagnostics services. In the United States, WELL provides omni-channel healthcare services and solutions targeting specialized markets such as the gastrointestinal market, women's health, primary care, and mental disorders. In addition to providing patient services, WELL develops, integrates, and sells its own suite of technology software and solutions to medical clinics and healthcare practitioners. WELL's practitioner enablement platform includes: Electronic Medical Records ("EMR"), telehealth platforms, practice management, billing, Revenue Cycle Management ("RCM"), digital health apps and data protection solutions. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF".

Read More

Digital Healthcare

REVIV Partners with Ten Health & Fitness

Businesswire | July 04, 2023

CEO for Retail Health, Sven Van Rossum, is pleased to announce the partnership between REVIV Global and Ten Health & Fitness. Ten Health & Fitness is one of London’s leading boutique fitness providers with 11 studios across the London capital, offering their customers expertly taught small group classes in a friendly and welcoming environment. Alongside their trademark Dynamic Reformer Pilates classes, Ten is renowned for its suite of wellness and fitness services, including Personal Training and exercise rehabilitation, Sports and Therapeutic massage, Women’s Health, and Clinical Exercise Prescription - a bespoke 1-1 programmes for clients living with a life-altering clinical diagnosis. All with the aim of delivering an enjoyable, empowering and supportive client experience that achieves results. As a part of their holistic approach Ten has expanded the scale of its wellness offer, with its new Kings Cross flagship studio pioneering the introduction of cryotherapy, infrared saunas and now the game-changing collaboration with REVIV to provide IV drip therapy and IM booster shots. “The partnership with REVIV perfectly rounds out Ten’s wellness offering. REVIV’s range of infusions and booster shots beautifully complement our other wellness services and it’s also a great way for us to enhance the experience and results we can offer our fitness and therapy clients,” explains Ten’s Brand Director, Justin Rogers. “We’re understandably proud of our reputation for expertise, and the quality of REVIV’s products and the expertise of their team make them an ideal fit for us.” Sven Van Rossum, CEO Retail Health at REVIV, says: “We are thrilled to announce our collaboration with Ten Health & Fitness, a powerful alliance driven by our shared commitment to empowering individuals to embrace their health and wellness and unlock their limitless potential. Together, we will provide impactful solutions that enable our customers to take control of their wellbeing and achieve remarkable results. We can’t wait to see the positive impact it will have on our customers.” About REVIV REVIV is a life science led provider of nutritional health solutions, and their goal is to be the only personalized nutritional health company that offers precision nutrition solutions, using big data coupled with AI, to evidence that nutrition can have a positive impact on medical conditions or disease. REVIV’s vision is to pioneer the democratization of nutrition-based treatments which will reduce disease, extend life and allow people to live better and healthier lives.

Read More

AI, Healthcare Analytics

Hyro Partners with Gozio Health to Integrate AI-Powered Communications with Mobile Solutions for Patients

PRNewswire | July 31, 2023

Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, customizable, location-aware mobile patient engagement platform. Hyro will embed its conversational AI platform within Gozio's framework, providing quality omnichannel voice and chat AI experiences to patients and staff through mobile applications. The partnership will initially be rolled out across the two companies' mutual customer base of healthcare providers, including Novant Health and Baptist Health. Hyro's Adaptive Communications Platform will augment Gozio's suite of mobile offerings and give enterprise health systems access to integrated AI assistants for patient-facing tasks such as prescription refills, FAQ resolution, appointment management, and troubleshooting. Together, Gozio and Hyro enable healthcare organizations to automate routine tasks so that staff can devote their full attention to more urgent responsibilities, while also removing access barriers for patients by offering them a wider range of self-service capabilities in one centralized, user-friendly location. The partnership comes amid ballooning demand for AI technologies within healthcare providers' patient interfaces to further reduce inefficiencies and streamline routine tasks in an effort to optimize staff workflows. The healthcare industry, however, is sensitive and heavily regulated, particularly concerning patient data privacy and security. As such, responsible AI implementation to help both staff and patients while still protecting personal data is of paramount importance–a mission to which Gozio and Hyro are no strangers. Hyro reaches 60-70% resolution rates for inbound calls and messages while explaining the outputs of those AI-powered interactions, ensuring a greater degree of accountability and trust surrounding technologies like Large Language Models (LLMs) and Natural Language Understanding (NLU) "With burnout and staffing shortages so widespread in healthcare, any support we can offer to already overloaded contact centers is extremely valuable," said Israel Krush, CEO and Co-Founder, Hyro. "We welcome the opportunity to partner with Gozio, expanding our omnichannel AI-powered conversations relating to scheduling, Rx management, physician search and more to their seamless mobile interfaces. Now, patients can unlock 24/7 access to critical services from their healthcare providers with zero hold times and full confidence in their automated support." "With conversational AI having burst into the public spotlight throughout 2023, we are truly excited to bake Hyro's best-in-class conversational AI solution into our mobile app," said Lee Jones, Chief Product Officer at Gozio Health. "Hyro's explainable, plug-and-play conversational AI tools will allow the healthcare providers we work with to curate the datasets that AI draws upon, save stretched operational dollars, and maintain compliance with industry regulations." Through successful collaborations with leading health systems across the US, Hyro and Gozio will continue to provide healthcare enterprises with an unparalleled, all-in-one mobile app solution, ensuring seamless support and an enhanced user experience. "In today's world, we are used to having information right at our fingertips," said Melanie Husk, SVP, Chief Consumer Officer at Baptist Health. "Through embracing the joint capabilities of these two leading innovators in digital health, we will be able to automatically incorporate the latest developments in AI and mobile technology for the benefit of our patients at Baptist Health. Patients can now request services via phone call, SMS or directly through the mobile app, no matter the time or place, to ensure easy and real-time access to care." About Hyro Hyro, the leading Conversational AI Platform for Healthcare, enables health systems to automate workflows and conversations across their most valuable platforms, services and channels—including call centers, websites, SMS, mobile apps and more. Hyro's plug-and-play approach helps organizations recapture time and investment lost to building and maintaining chat and voice solutions. Hyro's clients, which include Intermountain Healthcare, Baptist Health, and Novant Health, benefit from AI assistants that are 60x faster to deploy, easy to maintain and simple to scale—generating better conversations, more conversions, and revenue-driving insights. Headquartered in New York, Hyro was founded in 2018 by Israel Krush and Rom Cohen. About Gozio Health Gozio Health partners with health systems to increase consumer engagement using a proven mobile platform and strategy. The entire healthcare journey–both in-person and digital–is improved by giving systems the flexibility to consolidate all their patient-facing digital solutions into one premium native mobile experience accessible by anyone, anywhere. Combined with Gozio's patented indoor positioning technology, the platform empowers consumers to confidently navigate their healthcare journey and enables health systems to more effectively achieve their business goals. Gozio customers surveyed in a 2021 KLAS Research Emerging Technology Spotlight report found 100% satisfaction.

Read More

Digital Healthcare

WELL's CRH Medical Continues Digitization Progress with Strategic Investment in Graphium Health

PRNewswire | June 26, 2023

WELL Health Technologies Corp. a practitioner focused digital health company that is positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to provide key business updates to its wholly owned subsidiary CRH Medical Corp. ("CRH"). CRH Medical, a subsidiary of WELL Health Technologies, announces a significant milestone in its pursuit of enhancing digitization across the CRH platform with the recent strategic investment in Graphium Health LP ("Graphium"). This investment marks a pivotal moment in CRH's history as it continues to prioritize technology enablement to deliver performance enhancement and improved patient experiences. In the fourth quarter of 2021, CRH embarked on a journey to transition its RCM service partners, aiming to modernize and optimize its overall RCM performance. This process revealed opportunities for CRH to leverage technologically enabled point solutions, including artificial intelligence (AI), process automation, data analytics, and patient-focused data science. Through these innovations, CRH is well on its way to transforming its RCM capabilities and disseminating these advancements throughout the broader WELL Health Technologies ecosystem. To capitalize on these opportunities, CRH has recently made a strategic investment in Graphium Health LP, a leading provider of electronic medical record (EMR) solutions primarily serving anesthesia practices in both inpatient and outpatient settings across the United States. CRH Anesthesia, a part of CRH, began a successful pilot program with Graphium's products in two sites under a commercial contract signed in 2022. Based on a recent pilot project with Graphium Health, CRH has demonstrated that it was able to: 1- reduce delays and as such expedite charge capture by 58% or 5.6 days and 2- Reduce its overall AR at the sites affected by the pilot project by 24%. As a result of this investment, CRH Medical plans to expand this initiative to at least 54 additional ambulatory surgical centers (ASCs) over the next three years, where CRH provides anesthesia services. Notably, nearly one-third of CRH Anesthesia's sites currently operate without an EMR, relying solely on paper-based systems. By implementing Graphium's software in these ASCs, CRH will achieve full EMR digitization across its entire platform, ensuring seamless integration and streamlined operations. CRH has made numerous advancements to digitize its business since its acquisition by WELL more than two years ago, resulting in several tangible business improvements, including improving insurance and patient accounts receivable recovery, enhancing denial management performance, and expediting charge capture reconciliation. "We are thrilled to announce our strategic investment in Graphium Health. This transition to advanced technology solutions aligns perfectly with our commitment to improving performance and enhancing the provider and partner experience," said Jay Kreger, CEO of CRH. "By harnessing the power of artificial intelligence, process automation, and data analytics, we are empowering our team to deliver more accurate billing information, expedite charge capture reconciliation, and drive improved collections. This investment reinforces our dedication to digitization and innovation in healthcare technology." The investment in Graphium Health aligns with WELL Health Technologies' original thesis for acquiring CRH Medical, emphasizing the realization of digitization benefits across the CRH Medical platform and helping "tech enable" care providers and their support personnel. Preliminary findings from the implementation of Graphium's software have demonstrated the potential for significant RCM improvements, including quicker and more accurate billing information. After broader implementation across CRH's ASCs, Graphium's software is expected to holistically drive improved collections and enhanced data mining capabilities to deliver better analytics across the platform. WELL Health Technologies remains committed to driving digitization efforts at CRH Medical, empowering healthcare providers to deliver better and more efficient care to their patients. Through ongoing innovation and strategic investments, WELL, through CRH, further establishes itself as a leader in healthcare technology solutions. About WELL Health Technologies Corp. WELL is a practitioner-focused digital healthcare company. WELL's overarching mission is to positively impact health outcomes by leveraging technology to empower healthcare practitioners and their patients globally. WELL exists to enable healthcare practitioners with best-in-class technology and services. WELL has built the most comprehensive end-to-end healthcare system across Canada including the nation's largest network of clinics supporting primary care, specialized care, and diagnostics services. In the United States, WELL provides omni-channel healthcare services and solutions targeting specialized markets such as the gastrointestinal market, women's health, primary care, and mental disorders. In addition to providing patient services, WELL develops, integrates, and sells its own suite of technology software and solutions to medical clinics and healthcare practitioners. WELL's practitioner enablement platform includes: Electronic Medical Records ("EMR"), telehealth platforms, practice management, billing, Revenue Cycle Management ("RCM"), digital health apps and data protection solutions. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on the OTC Exchange under the symbol "WHTCF".

Read More

Digital Healthcare

REVIV Partners with Ten Health & Fitness

Businesswire | July 04, 2023

CEO for Retail Health, Sven Van Rossum, is pleased to announce the partnership between REVIV Global and Ten Health & Fitness. Ten Health & Fitness is one of London’s leading boutique fitness providers with 11 studios across the London capital, offering their customers expertly taught small group classes in a friendly and welcoming environment. Alongside their trademark Dynamic Reformer Pilates classes, Ten is renowned for its suite of wellness and fitness services, including Personal Training and exercise rehabilitation, Sports and Therapeutic massage, Women’s Health, and Clinical Exercise Prescription - a bespoke 1-1 programmes for clients living with a life-altering clinical diagnosis. All with the aim of delivering an enjoyable, empowering and supportive client experience that achieves results. As a part of their holistic approach Ten has expanded the scale of its wellness offer, with its new Kings Cross flagship studio pioneering the introduction of cryotherapy, infrared saunas and now the game-changing collaboration with REVIV to provide IV drip therapy and IM booster shots. “The partnership with REVIV perfectly rounds out Ten’s wellness offering. REVIV’s range of infusions and booster shots beautifully complement our other wellness services and it’s also a great way for us to enhance the experience and results we can offer our fitness and therapy clients,” explains Ten’s Brand Director, Justin Rogers. “We’re understandably proud of our reputation for expertise, and the quality of REVIV’s products and the expertise of their team make them an ideal fit for us.” Sven Van Rossum, CEO Retail Health at REVIV, says: “We are thrilled to announce our collaboration with Ten Health & Fitness, a powerful alliance driven by our shared commitment to empowering individuals to embrace their health and wellness and unlock their limitless potential. Together, we will provide impactful solutions that enable our customers to take control of their wellbeing and achieve remarkable results. We can’t wait to see the positive impact it will have on our customers.” About REVIV REVIV is a life science led provider of nutritional health solutions, and their goal is to be the only personalized nutritional health company that offers precision nutrition solutions, using big data coupled with AI, to evidence that nutrition can have a positive impact on medical conditions or disease. REVIV’s vision is to pioneer the democratization of nutrition-based treatments which will reduce disease, extend life and allow people to live better and healthier lives.

Read More

More featured news